FdaApplication
ANDA 212117
Identifiers
- fda_app_no: ANDA212117
Properties
| Property | Value |
|---|---|
| applicant_name | NIVAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2020-12-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DECITABINE | DECITABINE | 50MG/VIAL | INJECTABLE;INTRAVENOUS |
1 product